OSA-related hypoxemia linked to increased frontoparietal cerebrovascular pathology, which is associated with reduced medial temporal lobe integrity.

Preliminary screening for OSA in children who are awake, performed via an EEG, may help identify whether oxygen desaturation occurs at night.

IHL-42X is designed to treat OSA by targeting its underlying pathophysiology. An oral fixed-dose combination of dronabinol and acetazolamide, IHL-42X is currently advancing through the RePOSA Phase ...